Brief: Diagonal Bio Q1 Operating Loss Widens To SEK 3.4 Million

Diagonal Bio AB

11/05/2022 07:18

May 11 (Reuters) - Diagonal Bio AB  9F1.F :
    * Q1 REVENUES AMOUNTED TO SEK 597 THOUSAND (SEK 2,858
THOUSAND)
    * Q1 OPERATING PROFIT AMOUNTED TO SEK -3,376 THOUSAND (-727
THOUSAND)

Source text for Eikon:  ID:nWkrV00jz 
Further company coverage:  9F1.F 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))